JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
Investing.com -- Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) stock surged 100% after the company announced the launch of its diaper rash product in Walmart stores and other major U.S. retail chains.
The healthcare company revealed that its antimicrobial hydrogel product, based on its patented Microcyn technology using stabilized hypochlorous acid (HOCl), is now available in 3,600 Walmart locations, on Amazon.com, and in several large grocery chains across the United States.
This marks Sonoma’s first major entry into the over-the-counter consumer market through large-scale retail channels. The product is being distributed through the company’s U.S.-based distribution partner.
"We are excited to see our strategy of expanding into the over-the-counter space begin to take hold with our first U.S. product targeted to consumers launched into large scale retail channels," said Amy Trombly, CEO of Sonoma. "We are also pleased about the increased availability of our Microcyn technology for consumers who seek safe and effective solutions for diaper rash and other skin irritations."
Sonoma Pharmaceuticals develops and produces a range of products using its Microcyn technology for various applications including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.